Financial Spine Prosthetic Disc Nucleus Market Set to Reach $265.8 Million by 2034, TMR Forecasts 8.2% CAGR – TMR Insights byJosh SandbergJanuary 28, 2025
Spine Centinel Spine® to Sponsor Major Worldwide Live Webinar Symposium on Cervical Disc Arthroplasty byTim AllenMarch 21, 2024
Spine BioRestorative Therapies Presents Preliminary Clinical Data from Phase 2 Study of BRTX-100 in Chronic Lumbar Disc Disease byJosh SandbergFebruary 5, 2024
Spine Five-Year Study Outcomes of the NuVasive Simplify Cervical Disc were Presented at the North American Spine Society 38th Annual Meeting byJosh SandbergOctober 24, 2023
Biologics Spine BioRestorative Therapies Announces Activation of Northwell Health in the Company’s Phase 2 Clinical Trial Targeting Chronic Lumbar Disc Disease byJosh SandbergSeptember 8, 2023
Biologics BioRestorative Therapies Announces Key Milestone of Dosing Completion in Safety Cohort of Phase 2 Trial Targeting Chronic Lumbar Disc Disease byJosh SandbergJune 12, 2023
Spine Orthofix Announces Presentation of Long-Term Evidence Highlighting the Clinical Management of Cervical Disc Arthroplasty at North American Spine Society Annual Meeting byChris StewartOctober 10, 2022
Financial Spine Artificial Cervical Intervertebral Disc Market Size Worth $4.37 Bn Globally, by 2028 at 18.0% CAGR – Exclusive Report by The Insight Partners byJosh SandbergJuly 25, 2022
Biologics Spine BioRestorative Therapies Announces First Patient Enrolled for the Company’s Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease (cLDD) byChris StewartJune 30, 2022
Biologics Spine BioRestorative Therapies Announces Clinical Trial Contract with Second Site for the Company’s Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease (cLDD) byChris StewartJune 22, 2022
